APX and Revelle Enter Strategic Partnership
The partnership between APX and Revelle aims to help aesthetic practices accelerate growth and productivity.
The partnership between APX and Revelle aims to help aesthetic practices accelerate growth and productivity.
Available in the EU, UK, and Switzerland, the device is designed for in-office preparation of autologous PRP and Fluid-PRF.
Galderma commits to including menopausal status in all injectable aesthetics clinical trials following global study of over 4,300 women.